Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Evolving High Content Screening With the IX83 Inverted Microscope Frame

Published: Thursday, July 25, 2013
Last Updated: Thursday, July 25, 2013
Bookmark and Share
Olympus has expanded the scope of its most advanced IX83 inverted microscope frame, incorporating the scan^R 2.4 high content screening station for greater flexibility and increased scan speeds in a range of cell-based assays.

The scan^R 2.4 high content screening station is the latest addition to the growing collection of microscopy systems based upon the new IX3 high-end inverted microscope frame.

Thanks to its unique “open source” design concept, the IX3 is offering a completely modular and flexible approach to live cell imaging.

Built around a swappable deck design, optical modules can be easily exchanged into the accessible infinite light path, moulding the IX3 microscope to the diverse requirements of the user.

The updated Olympus scan^R 2.4 high content screening station can now be incorporated with the most advanced model of the IX3 range, the fully automated IX83, combining benefits of a modular frame design with increased scan speed.

This new system delivers quantitative expert results in a vast array of high content screening of cell-based assays, from gene expression to bacterial infection assays.

Keeping pace with the IX3 platform, the scan^R 2.4 software capabilities have also been extended, including fully supported multi-core analysis and unique kinetic analysis for advanced microscopy techniques.

Furthermore, cell population data can be easily exported so users can jointly benefit from all the flexibility offered by complex experiments in the Olympus xcellence imaging software.

The workflow-orientated graphical user interface has also been updated, allowing the advanced capabilities of the scan^R 2.4 station to be operated in a straightforward and intuitive manner, for routine and highly complex assays alike.

These new features build upon the performance of the scan^R stations’ high speed image acquisition and analysis. The dedicated real-time controller ensures precise timing of image capture, avoiding photobleaching and phototoxicity while maintaining the optimum scan speed.

Designed to be flexible to user requirements, the scan^R 2.4 station is optimized for many different assay formats, including multi-well plates, slides and custom-built arrays.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
Angina Drug Could Inform A New Strategy To Fight Cryptococcosis
A drug, more commonly used in the treatment of angina, could be the focus of a new strategy in fighting the fatal fungal infection cryptococcosis.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!